Conventional treatment

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	3

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05610956 (ClinicalTrials.gov)	December 1, 2022	31/10/2022	Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy and Safety of Empagliflozin in Patients With Ulcera ...	Ulcerative Colitis	Drug: Empagliflozin;Drug: conventional treatment	Tanta University	NULL	Not yet recruiting	18 Years	70 Years	All	60	Early Phase 1	NULL
2	NCT05386290 (ClinicalTrials.gov)	July 9, 2020	17/5/2022	A Multicentered Prospective Cohort Study of Chinese IBD Patients	A Multicentered Prospective Cohort Study of Chinese IBD Patients Concerning Cost-effectiveness Analy ...	Ulcerative Colitis;Crohn Disease	Drug: Infliximab;Drug: Vedolizumab;Drug: Ustekinumab;Drug: conventional treatment(glucocoticoid, imm ...	Peking Union Medical College Hospital	NULL	Enrolling by invitation	14 Years	80 Years	All	200		China
3	EUCTR2012-004768-23-DE (EUCTR)	12/06/2013	06/02/2013	A Phase 2a Trial of STNM01 by a Single Submucosal Injection to Investigate the Mucosal Healing Effic ...	A Phase 2a Trial of STNM01 by a Single Submucosal Injection to Investigate the Mucosal Healing Effic ...	Ulcerative Colitis with active endoscopic lesion(s), ranging in severity from moderate to severe in ...	Product Name: STNM01 1.84 mg Product Code: STNM01 INN or Proposed INN: STNM01	STELIC INSTITUTE & CO.	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Germany

First Previous1Next Last